Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol

NCT01808131 is registered in ClinicalTrials.gov with Ardea Biosciences, Inc. as lead sponsor.

NCT NCT01808131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01808131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Lead sponsor
Ardea Biosciences, Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2013
Completion date
November 30, 2016
Enrollment
717 (actual)
Sites
207

Conditions

As the registry lists them; a condition with its own page is linked.

gout